BIG
ALNY icon

Brooklyn Investment Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Brooklyn Investment Group’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$330K Buy
997
+349
+54% +$119K 0.01% 1347
2025
Q4 		$258K Buy
+648
New +$287K 0.01% 1173
2025
Q3 		– Sell
-481
Closed -$157K – 745
2025
Q2 		$157K Buy
481
+78
+19% +$21.6K 0.02% 720
2025
Q1 		$109K Sell
403
-14
-3% -$3.6K 0.02% 512
2024
Q4 		$98.1K Buy
417
+4
+1% +$1.05K 0.03% 372
2024
Q3 		$114K Buy
+413
New +$108K 0.04% 329

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Brooklyn Investment Group's ALNY Position: Q1 2026 in Review

Brooklyn Investment Group increased its Alnylam Pharmaceuticals (ALNY) stake by 54% in Q1 2026, buying an estimated $119K and bringing the position to 997 shares worth $330K. The position accounts for 0.01% of the portfolio, ranked #1347.

Brooklyn Investment Group first reported a position in ALNY in Q3 2024 and has held it in 6 quarters since. 793 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

  • Brooklyn Investment Group held 997 shares of Alnylam Pharmaceuticals worth $330K as of Q1 2026.
  • Brooklyn Investment Group bought 349 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $119K.
  • Alnylam Pharmaceuticals made up 0.01% of Brooklyn Investment Group's portfolio in Q1 2026, its #1347 holding.
  • Brooklyn Investment Group first reported a position in Alnylam Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.